• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
For: Aomar-Millán IF, Salvatierra J, Callejas-Rubio JL, Raya-Álvarez E. [Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: coment]. Reumatol Clin 2023;19:120-121. [PMID: 35165530 PMCID: PMC8828423 DOI: 10.1016/j.reuma.2022.01.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Indexed: 02/01/2023]
Number Cited by Other Article(s)
1
Figuero-Pérez L, Olivares-Hernández A, Escala-Cornejo RA, Cruz-Hernández JJ. [Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection]. Reumatol Clin 2023;19:121. [PMID: 35308807 PMCID: PMC8919784 DOI: 10.1016/j.reuma.2022.02.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
2
Figuero-Pérez L, Olivares-Hernández A, Escala-Cornejo RA, Cruz-Hernández JJ. Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection. Reumatol Clin (Engl Ed) 2023;19:121. [PMID: 35760706 PMCID: PMC9226967 DOI: 10.1016/j.reumae.2022.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Accepted: 02/04/2022] [Indexed: 02/06/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA